News
Investors are betting that Lilly will maintain its momentum. Its share price has climbed by a third since the start of 2024; Novo’s has fallen by as much (see chart 2). Lilly’s edge rests on a more ...
Pharmaceutical company Charles River Laboratories has reached a settlement with activist investor Elliott Investment ...
A man is suing the manufacturers of Ozempic, alleging the diabetes drug caused him to go blind. The medication, containing semaglutide, works by regulating blood sugar and suppressing hunger. While ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results